When Germany introduced reimbursement for prescription digital health applications in 2020, it became the first country to create a national pathway for digital therapeutics to enter routine healthcare. The policy, embedded in the Digital Healthcare Act (Digitale-Versorgung-Gesetz), allowed physicians to prescribe certified medical apps (known as Digital Health Applications, or DiGAs) and have them reimbursed… Continue reading Germany’s DiGA Programme: the Evolution of Digital Therapeutics Reimbursement
Category: Health Technology Assessments
The Role of Real-World Data in HTA Reassessments
Health technology assessments (HTAs) are the foundation of evidence-based decision-making for reimbursement, and coverage of medicines and medical technologies. Traditionally, the process has been heavily anchored in evidence from randomized controlled trials (RCTs), assessed at the time of market entry. However, healthcare systems have been evolving and are increasingly shifting toward a lifecycle approach to… Continue reading The Role of Real-World Data in HTA Reassessments